Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2, 4, and 6 months
Awards & highlights
MOVES Trial Summary
This trial is testing whether a home-based intervention can help people with lupus be more active and less fatigued.
Eligible Conditions
- Lupus
MOVES Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 2, 4, and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2, 4, and 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Exercise over time
Change in physical activity over time
Secondary outcome measures
Change in Fatigue Severity Scale over time
MOVES Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
The experimental intervention is a 16-week progressive home-based exercise program in which participants are supported through seven coaching calls based on social cognitive theory and motivational interviewing principles. The individual sessions will provide tailored support for increasing physical activity behavior towards the recommended guidelines of at least 150 minutes of moderate aerobic activity and two strength-training sessions per week. There are no drugs involved in the intervention.
Group II: Waitlist ControlActive Control1 Intervention
24-week waitlist control condition
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MOVES
2022
N/A
~40
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,795 Previous Clinical Trials
6,373,904 Total Patients Enrolled
Lupus Foundation of AmericaUNKNOWN
2 Previous Clinical Trials
9,624 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with Lupus.You feel very tired and have a score of 36 or higher on the fatigue severity scale.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental
- Group 2: Waitlist Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger